Myriad Genetics Inc. (MYGN)
NASDAQ: MYGN
· Real-Time Price · USD
5.71
-0.18 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
5.66
-0.96%
After-hours: Aug 15, 2025, 05:30 PM EDT
Myriad Genetics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 832.9M | 831.3M | 837.6M | 823.6M | 802.2M | 774.2M | 753.2M | 734.4M | 698.9M | 694.7M | 678.4M | 661.4M | 672.3M | 682.4M | 690.6M | 684.4M | 662.3M | 566.1M |
Cost of Revenue | 246.2M | 249.3M | 252.2M | 254.1M | 248.2M | 241.6M | 236.2M | 228.5M | 221.3M | 213.2M | 202M | 193.9M | 191.3M | 195.3M | 197.6M | 198.9M | 195.3M | 178.3M |
Gross Profit | 586.7M | 582M | 585.4M | 569.5M | 554M | 532.6M | 517M | 505.9M | 477.6M | 481.5M | 476.4M | 467.5M | 481M | 487.1M | 493M | 485.5M | 467M | 387.8M |
Operating Income | -417.2M | -124.5M | -123.4M | -115.8M | -155.9M | -233.1M | -257.4M | -272M | -256.9M | -161M | -123.7M | -120.8M | -155.7M | -158.7M | -190.5M | -195.6M | -155.3M | -202.8M |
Interest Income | 1.2M | 1.4M | 1.7M | 2.1M | 2.3M | 2.4M | 2.5M | 2.8M | 3.3M | 3.2M | 2.6M | 1.7M | 800K | 600K | 700K | 900K | 1.1M | 1.4M |
Pretax Income | -420.3M | -126.9M | -123.4M | -116.6M | -156.6M | -235.5M | -262.2M | -282M | -265M | -166.8M | -140.6M | -132M | -48M | -33.9M | -57.1M | -69.3M | -152.8M | -207.5M |
Net Income | -395.2M | -101.4M | -127.3M | -116M | -155.2M | -234.6M | -263.3M | -274.4M | -248.2M | -146.2M | -112M | -77.3M | -17.6M | -8.2M | -27.2M | -63.8M | -103.6M | -154.3M |
Selling & General & Admin | 549.5M | 555.7M | 560.6M | 457.2M | 488.5M | 561.8M | 572.9M | 686.8M | 646.9M | 555.8M | 514.7M | 509.7M | 559.4M | 567.1M | 602M | 593.4M | 537.3M | 509.9M |
Research & Development | 113.8M | 115.3M | 112.7M | 101.5M | 97M | 91.1M | 88.7M | 91.1M | 87.6M | 86.7M | 85.4M | 78.6M | 76.9M | 76.1M | 78M | 79.6M | 78.4M | 76.3M |
Other Expenses | 340.6M | 35.5M | 35.5M | 126.6M | 123.7M | 112.1M | 111.5M | -1.3M | -100K | n/a | 600K | 500K | n/a | -100K | -200K | -100K | -100K | -100K |
Operating Expenses | 1B | 706.5M | 708.8M | 685.3M | 709.9M | 765.7M | 774.4M | 777.9M | 734.5M | 642.5M | 600.1M | 588.3M | 636.3M | 643.2M | 680M | 673M | 615.7M | 586.2M |
Interest Expense | 3.8M | 3.1M | 2.8M | 3M | 3.2M | 2.9M | 2.9M | 2.9M | 2.7M | 2.8M | 3.2M | 2.8M | 3.1M | 4.5M | 6.6M | 9M | 10.8M | 11.9M |
Selling & Marketing Expenses | 425.2M | 353.3M | 284.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.25B | 955.8M | 961M | 939.4M | 958.1M | 1.01B | 1.01B | 1.01B | 955.8M | 855.7M | 802.1M | 782.2M | 827.6M | 838.5M | 877.6M | 871.9M | 811M | 764.5M |
Income Tax Expense | -25.1M | -25.5M | 3.9M | -600K | -1.4M | -2.8M | -800K | -9.5M | -18.7M | -20.6M | -28.6M | -54.7M | -30.4M | -25.7M | -29.9M | -5.5M | -49.2M | -53.1M |
Shares Outstanding (Basic) | 92.5M | 91.4M | 91.1M | 90.9M | 90.6M | 89.9M | 86.1M | 81.73M | 81.7M | 81.3M | 81.5M | 80.7M | 78.33M | 78.85M | 76.14M | 78.8M | 77.2M | 75.96M |
Shares Outstanding (Diluted) | 92.5M | 91.4M | 91.1M | 90.9M | 90.6M | 89.9M | 86.1M | 81.9M | 81.7M | 81.3M | 81.5M | 80.7M | 80.4M | 80.1M | 79.9M | 81.5M | 77.2M | 76M |
EPS (Basic) | -4.28 | -1.12 | -1.41 | -1.3 | -1.81 | -2.82 | -3.2 | -3.36 | -3.04 | -1.8 | -1.39 | -0.97 | -0.23 | -0.11 | -0.37 | -0.86 | -1.37 | -2.05 |
EPS (Diluted) | -4.28 | -1.12 | -1.41 | -1.3 | -1.81 | -2.82 | -3.2 | -3.36 | -3.04 | -1.8 | -1.39 | -0.97 | -0.24 | -0.12 | -0.38 | -0.87 | -1.37 | -2.05 |
EBITDA | -355M | -61.2M | -56.7M | -49.4M | -93.3M | -174.4M | -197.4M | -212.4M | -196.6M | -98.7M | -67.8M | -66.2M | 19.6M | 41.3M | 15.8M | -2.7M | -82.4M | -137.4M |
EBIT | -416.5M | -123.8M | -120.6M | -113.6M | -153.3M | -116.9M | -143.7M | -158.3M | -143.2M | -161M | -123.7M | -120.8M | -75.8M | -58M | -43.1M | n/a | n/a | n/a |
Depreciation & Amortization | 58.9M | 59.9M | 61.2M | 61.5M | 60M | 58.2M | 62M | 61.6M | 62.2M | 62.3M | 55.9M | 54.5M | 54M | 57.5M | 62.8M | 67.6M | 71.1M | 71.9M |